Editor's note: This podcast is produced by Innovate Fort Worth, a service of the UNT Health Science Center's Innovation Ecosystems. Cameron Cushman, assistant vice president of the Innovation Ecosystems, hosts the podcast. He also is member of the reader advisory council of the Fort Worth Report.
More than 6 million Americans are living with Alzheimer’s Disease, and even more with Dementia and Parkinson’s. CX Precision Medicine’s CEO, Danguole Altman, is focused on tackling this big problem for an aging population. Based on Dr. Sid O’Bryant’s revolutionary research at HSC, CX Precision Medicine is bringing this important diagnostic technology to help people all over the world. Through a clinical diagnostic, CX Precision Medicine is conducting screening tests to detect Alzheimer’s and other neurodegenerative diseases based on blood biomarkers, AI and machine learning. CX aims to “Change eXpectations” around how doctors diagnose Alzheimer’s and dementia.
Want to learn more? Listen to episodes 20 and 21 with Dr. Sid O’Bryant to learn more about his research.
To learn more about CX Precision Medicine, visit their website at https://cxprecisionm.com
To learn more about HSC Next, visit https://www.hscnext.com